Eliah Overbey Ph.D. is Professor of Bioastronautics at the University of Austin, and also serves at Weill Cornell Medicine and as Chief Scientific Officer at BioAstra. Her research examines how spaceflight alters the molecular biology of astronauts, drawing on subjects from commercial missions with SpaceX and Blue Origin.